Edition:
United States

Lantheus Holdings Inc (LNTH.OQ)

LNTH.OQ on NASDAQ Stock Exchange Global Market

22.70USD
24 Nov 2017
Change (% chg)

$-0.10 (-0.44%)
Prev Close
$22.80
Open
$22.90
Day's High
$23.00
Day's Low
$22.40
Volume
35,196
Avg. Vol
125,951
52-wk High
$24.10
52-wk Low
$7.95

Latest Key Developments (Source: Significant Developments)

Lantheus Holdings reports Q3 earnings per share $0.22
Thursday, 2 Nov 2017 04:02pm EDT 

Nov 2 (Reuters) - Lantheus Holdings Inc :Lantheus Holdings Inc reports 2017 third quarter financial results; exceeds third quarter and raises full-year 2017 guidance.Q3 earnings per share $0.22.Q3 revenue $79.9 million versus I/B/E/S view $77.3 million.Sees fy 2017 revenue $323 million to $325 million.Q3 earnings per share view $0.21 -- Thomson Reuters I/B/E/S.Lantheus Holdings Inc - ‍increased its full-year 2017 guidance range for adjusted EBITDA to $86 million to $88 million from previous guidance of $82 million to $85 million​.Lantheus Holdings Inc - fy guidance for both revenue and adjusted EBITDA excludes impact of a $5.0 million up-front payment received in q2 of 2017 from GE Healthcare​.  Full Article

Lantheus Holdings Q2 earnings per share $0.35
Tuesday, 1 Aug 2017 04:02pm EDT 

Aug 1 (Reuters) - Lantheus Holdings Inc :Lantheus Holdings, Inc. reports 2017 second quarter financial results; exceeds second quarter and raises full-year 2017 guidance.Q2 earnings per share $0.35.Q2 revenue $88.8 million versus I/B/E/S view $80.6 million.Q2 earnings per share view $0.23 -- Thomson Reuters I/B/E/S.Sees Q3 2017 revenue $75 million to $78 million.Sees FY 2017 revenue $318 million to $322 million.Lantheus Holdings Inc - ‍increased its full-year 2017 guidance range for adjusted EBITDA to $82 million to $85 million​.Lantheus Holdings Inc - ‍for Q3 of 2017, company expects adjusted EBITDA in range of $17 million to $19 million​.Q3 revenue view $77.4 million -- Thomson Reuters I/B/E/S.FY2017 revenue view $317.3 million -- Thomson Reuters I/B/E/S.  Full Article

Lantheus Holdings sees Q2 revenue $79 mln-$82 mln
Tuesday, 2 May 2017 04:02pm EDT 

May 2 (Reuters) - Lantheus Holdings Inc :Lantheus Holdings, Inc. Reports 2017 first quarter financial results; exceeds first quarter and raises full-year 2017 guidance.Q1 earnings per share $0.11.Q1 revenue $81.4 million versus i/b/e/s view $78.2 million.Q1 earnings per share view $0.19 -- Thomson Reuters I/B/E/S.Q1 adjusted non-gaap earnings per share $0.28.Sees q2 2017 revenue $79 million to $82 million.Sees fy 2017 revenue $313 million to $318 million.Lantheus Holdings Inc - expects worldwide revenues in range of $79 million to $82 million for q2 of 2017.Lantheus Holdings Inc - for q2 of 2017, company expects adjusted ebitda in range of $18 million to $20 million.Lantheus Holdings Inc - guidance for both revenue and adjusted ebitda excludes impact of $5.0 million received from ge healthcare in april.Lantheus Holdings Inc - company has also increased its full-year 2017 guidance range for adjusted ebitda to $80 million to $83 million.Fy2017 revenue view $315.1 million -- Thomson Reuters I/B/E/S.  Full Article

Lantheus and GE Healthcare announce the signing of a definitive license agreement for worldwide development and commercialization of Flurpiridaz F 18
Tuesday, 25 Apr 2017 08:00am EDT 

April 25 (Reuters) - General Electric Co :Lantheus and GE Healthcare announce the signing of a definitive license agreement for worldwide development and commercialization of Flurpiridaz F 18.Lantheus Holdings - Under the agreement, GE Healthcare will lead and fund development program of Flurpiridaz F18, including second phase III clinical study.Lantheus Holdings says it will receive $5 million upfront cash payment and, if successful, up to $60 million in regulatory and sales milestones payments.  Full Article

Lantheus Holdings reports Q4 EPS $0.13
Tuesday, 21 Feb 2017 04:02pm EST 

Lantheus Holdings Inc : Reports 2016 fourth quarter and full year financial results; provides 2017 guidance . Q4 earnings per share $0.13 . Sees Q1 2017 revenue $77 million to $80 million . Sees FY 2017 revenue about $312 million to $317 million . Q4 revenue $74.4 million versus I/B/E/S view $70.8 million . Q4 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Says anticipates worldwide revenues for full year 2017 of approximately $312 million to $317 million, compared to $301.9 million in 2016 . Says for Q1 of 2017, company expects worldwide revenues in range of $77 million to $80 million . Anticipates full year 2017 adjusted ebitda of $79 million to $82 million . For Q1 of 2017 co expects adjusted EBITDA in range of $18 million to $20 million . Q4 revenue $74.4 million . FY2017 revenue view $312.2 million -- Thomson Reuters I/B/E/S .Q1 revenue view $77.8 million -- Thomson Reuters I/B/E/S.  Full Article

Lantheus Holdings & GE Healthcare announce the signing of a term sheet for worldwide development
Tuesday, 21 Feb 2017 04:00pm EST 

Lantheus Holdings Inc : Lantheus Holdings and GE Healthcare announce the signing of a term sheet for worldwide development and commercialization of flurpiridaz F 18 . Lantheus Holdings Inc - LMI would receive a $5 million upfront cash payment and, if successful, up to $60 million in regulatory and sales milestones payments . Lantheus Holdings Inc - GE Healthcare would fund second phase III flurpiridaz F 18 clinical study, worldwide regulatory approvals . Lantheus Holdings Inc - LMI would receive a usd 5 million upfront cash payment . Lantheus Holdings Inc - GE Healthcare would also fund flurpiridaz's worldwide launch and commercialization .Says parties anticipate entering into a definitive agreement for proposed transaction in Q2 of 2017.  Full Article

Lantheus Holdings announces public offering of 3 mln shares of common stock
Tuesday, 15 Nov 2016 04:22pm EST 

Lantheus Holdings Inc : Lantheus Holdings-intends to use net proceeds, with cash on hand,to repay about $20 million of outstanding principal balance under senior credit facilities . Lantheus Holdings Inc - offering expected to consist of 1 million shares to be offered by co & 2 million shares to be offered by certain existing stockholders .Lantheus Holdings, Inc announces public offering of 3,000,000 shares of common stock.  Full Article

Lantheus Holdings sells radiopharmacy servicing business in Australia
Thursday, 11 Aug 2016 05:13pm EDT 

Lantheus Holdings Inc : Lantheus Holdings Inc says sale of its radiopharmacy servicing business in Australia to Global Medical Solutions, Ltd . Lantheus Holdings announces divestiture of its Australian radiopharmacy servicing business and entry into long-term supply and distribution agreement . LMI and Global Medical Solutions also entered into a long-term supply and distribution contract .Has appointed GMS as a distributor of its radiopharmaceuticals, including nuclear medicine products and cold kits, in Australia.  Full Article

Lantheus files for mixed shelf of up to $50 mln - SEC filing
Friday, 5 Aug 2016 04:07pm EDT 

Lantheus Holdings Inc : Files for mixed shelf of up to $50 million - sec filing .In addition, selling stockholders may offer and sell up to 17.8 million shares of common stock..  Full Article

Lantheus Holdings Q2 earnings per share $0.24
Thursday, 4 Aug 2016 04:02pm EDT 

Lantheus Holdings Inc : Lantheus Holdings, Inc. reports 2016 second quarter financial results . Sees Q3 2016 revenue $68 million to $70 million . Q2 earnings per share view $0.06 -- Thomson Reuters I/B/E/S . Sees fy 2016 revenue $291 million to $295 million . Q2 earnings per share $0.24 . Q2 revenue $78 million versus I/B/E/S view $72.7 million . For Q3 of 2016, company expects adjusted EBITDA in range of $14 million to $16 million. .Increasing its outlook for full year 2016 adjusted ebitda to a range of $70 million to $73 million.  Full Article

BRIEF-Lantheus Holdings reports Q3 earnings per share $0.22

* Lantheus Holdings Inc reports 2017 third quarter financial results; exceeds third quarter and raises full-year 2017 guidance